Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2014-06-05 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2014年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '2014 年第一次临时股东大会决议公告' which translates to '2014 First Extraordinary General Meeting Resolution Announcement'. It details the convening of a shareholders meeting, attendance, voting results on proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the announcement of the resolutions passed at the shareholders meeting rather than the meeting materials or the full report. The document length is short (1387 characters), and it serves as an official announcement of voting results from a shareholders meeting. Therefore, it fits the category 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2014-06-05 Chinese
2014年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and results of a 2014 first extraordinary general meeting (临时股东大会) of the company 三诺生物传感股份有限公司. It details the legality and validity of the meeting's call, attendance, and voting results. It does not contain financial statements or management discussion but is a legal certification related to a shareholder meeting. This fits the category of a Regulatory Filing (RNS) as it is a legal opinion on a corporate event rather than a report or announcement of financial results or governance changes.
2014-06-05 Chinese
北京国枫凯文律师事务所关于公司调整股票期权与限制性股票激励计划相关事项的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding adjustments to a company's stock option and restricted stock incentive plan. It references specific legal and regulatory frameworks, company resolutions, and approvals related to the incentive plan. The document does not contain financial statements or performance data, nor is it an announcement of a report publication. It is a legal proceeding related to corporate governance and compliance with securities laws concerning stock incentives. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is under 5,000 characters, but it is not a mere announcement; it is a substantive legal opinion.
2014-05-16 Chinese
《公司章程》修订对照说明
Governance Information Classification · 95% confidence The document is titled '《公司章程》修订对照说明' which translates to 'Explanation of Amendments to the Articles of Association'. It details specific amendments to the company's articles of association, including changes to registered capital, business scope, and share structure. The document is an announcement of proposed changes to the company's governance documents, to be approved at a shareholders' meeting. It does not contain financial statements, audit information, or detailed management discussion. It is not a full report but a governance-related announcement. Therefore, it fits best under Governance Information (CGR). The document length is short and focused on governance amendments, not a report or announcement of a report publication.
2014-05-16 Chinese
第二届董事会第十一次（临时）会议（通讯方式）决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 11th meeting of the second board of directors of the company. It details decisions such as amendments to the company's articles of association, adjustments to the stock option and restricted stock incentive plan, and the scheduling of an extraordinary general meeting. The document includes voting results and procedural details but does not contain financial statements or detailed financial analysis. It is a formal announcement of board/management decisions rather than a full management report or financial report. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short (2002 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2014-05-16 Chinese
独立董事关于调整公司股票期权与限制性股票激励计划所涉股票期权授予数量、行权价格和预留限制性股票数量的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from the independent directors regarding adjustments to the company's stock option and restricted stock incentive plan, specifically about the number of stock options granted, exercise price, and reserved restricted stock quantity. It references relevant laws and regulations related to stock incentives and corporate governance. The content focuses on approval and opinion about changes in stock incentive plans rather than financial results, earnings, or management reports. It is not a full financial report, earnings release, or regulatory filing about financial performance. It is also not a proxy solicitation or voting result announcement. The document is a formal opinion related to corporate governance and stock incentive adjustments, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) because it is an opinion on adjustments rather than an announcement of new share issuance or capital change. The document length is short (1099 characters), and it is not an announcement of a report publication. Therefore, the best classification is Regulatory Filings (RNS).
2014-05-16 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.